Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 EUR | +2.34% | +1.16% | -4.89% |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.89% | 53.75M | |
+1.51% | 42.75B | |
+48.09% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PANG Stock
- News Pangaea Oncology, S.A.
- Pangaea Oncology, S.A. announced that it expects to receive €3.875 million in funding